FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35996511000001104: Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111214601000001116 Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111214701000001114 Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Is a Ranitidine 300mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has AMP Ranitidine 300mg tablets (Ennogen Pharma Ltd) true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has precise active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start